Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Primary Progressive Multiple Sclerosis
NCT00087529Phase 3Completed
- Sponsor
- Genentech
- Start
- Jun 2004
- Primary completion
- Oct 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in primary progressive multiple sclerosis (PPMS), sponsored by Genentech. Started Jun 2004; status: completed.
02
Drugs
rituximab
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on NCT00087529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087529.